Liver Fibrosis may Increase mortality risk among in patients of Ischemic Stroke
GREECE: Hepatic fibrosis, as measured by the FIB-4 index, may contribute as a significant risk factor for in-hospital mortality among individuals hospitalized with acute ischemic stroke in addition to being related to more severe ischemic stroke, states a study published in the Journal of Clinical Medicine.
"An elevated incidence of cardiovascular events, including ischemic stroke, is linked to nonalcoholic fatty liver disease, especially when hepatic fibrosis is present. Hepatic fibrosis may or may not affect the intensity and course of an acute ischemic stroke," mentioned the authors.
The investigators aimed to assess the association between hepatic fibrosis and the severity of acute ischemic stroke at admission and in-hospital prognosis.
They conducted a prospective analysis of all patients who suffered an acute ischemic stroke between September 2010 and February 2018 (n = 1107; 42.1% men; age 79.8 7.2 years). At admission, the National Institutes of Health Stroke Scale was used to determine the severity of the stroke (NIHSS). NIHSS 21 was the cutoff point for severe stroke. With the Fibrosis-4 index, the degree of hepatic fibrosis was assessed (FIB-4). A modified Rankin Scale between 2 and 5 was used to measure dependency at discharge, and in-hospital mortality was used to measure the outcome.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.